Brendan Harhen

988 total citations
27 papers, 778 citations indexed

About

Brendan Harhen is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Brendan Harhen has authored 27 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Brendan Harhen's work include Cannabis and Cannabinoid Research (10 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Brendan Harhen is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Brendan Harhen collaborates with scholars based in Ireland, United States and Sweden. Brendan Harhen's co-authors include David P. Finn, Michelle Roche, Desmond J. Fitzgerald, Helen M. Roche, Sinéad Toomey, Orina Belton, Gemma K. Ford, Corrado Santocanale, Michael D. Rainey and Bright N. Okine and has published in prestigious journals such as Scientific Reports, Brain Research and Pain.

In The Last Decade

Brendan Harhen

27 papers receiving 763 citations

Peers

Brendan Harhen
Brendan Harhen
Citations per year, relative to Brendan Harhen Brendan Harhen (= 1×) peers Joanna Listos

Countries citing papers authored by Brendan Harhen

Since Specialization
Citations

This map shows the geographic impact of Brendan Harhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan Harhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan Harhen more than expected).

Fields of papers citing papers by Brendan Harhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan Harhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan Harhen. The network helps show where Brendan Harhen may publish in the future.

Co-authorship network of co-authors of Brendan Harhen

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan Harhen. A scholar is included among the top collaborators of Brendan Harhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan Harhen. Brendan Harhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sorushanova, Anna, Eduardo Ribes Martínez, Anne Marie Quinn, et al.. (2024). Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma. Endocrinology. 166(1). 1 indexed citations
2.
Harhen, Brendan, John Ferguson, John W. McEvoy, et al.. (2022). Major disparities in patient‐reported adherence compared to objective assessment of adherence using mass spectrometry: A prospective study in a tertiary‐referral hypertension clinic. British Journal of Clinical Pharmacology. 89(7). 1948–1955. 7 indexed citations
3.
Okine, Bright N., et al.. (2020). Antinociceptive Effects of the GPR55 Antagonist CID16020046 Injected into the Rat Anterior Cingulate Cortex. Neuroscience. 443. 19–29. 15 indexed citations
4.
Hayes, Peter, Monica Casey, Liam Glynn, et al.. (2019). Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care. British Journal of General Practice. 69(686). e621–e628. 14 indexed citations
5.
Durand, Hannah, Peter Hayes, Brendan Harhen, et al.. (2018). Medication adherence for resistant hypertension: Assessing theoretical predictors of adherence using direct and indirect adherence measures. British Journal of Health Psychology. 23(4). 949–966. 36 indexed citations
8.
Ford, Gemma K., et al.. (2014). Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats. European Journal of Pain. 19(8). 1177–1185. 12 indexed citations
9.
Rea, Kieran, Gemma K. Ford, Weredeselam M. Olango, et al.. (2014). Microinjection of 2‐arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. European Journal of Neuroscience. 39(3). 435–443. 13 indexed citations
10.
Rainey, Michael D., Brendan Harhen, Guan‐Nan Wang, Paul V. Murphy, & Corrado Santocanale. (2013). Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpoint. Cell Cycle. 12(10). 1560–1568. 28 indexed citations
11.
Rea, Kieran, Weredeselam M. Olango, Bright N. Okine, et al.. (2013). Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli. Pain. 155(1). 69–79. 52 indexed citations
12.
Rea, Kieran, Weredeselam M. Olango, Brendan Harhen, et al.. (2012). Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats. Pain. 154(4). 576–585. 39 indexed citations
13.
Rainey, Michael D., et al.. (2011). DNA mediated chromatin pull-down for the study of chromatin replication. Scientific Reports. 1(1). 95–95. 47 indexed citations
14.
Kerr, Daniel M., Nikita N. Burke, Gemma K. Ford, et al.. (2011). Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor. Neuroscience. 204. 53–63. 55 indexed citations
16.
Hayes, Catherine, et al.. (2011). Cross Validation of Liquid Chromatography–Mass Spectrometry and Lectin Array for Monitoring Glycosylation in Fed-Batch Glycoprotein Production. Molecular Biotechnology. 51(3). 272–282. 11 indexed citations
17.
Harney, D., Michelle Dooley, Brendan Harhen, et al.. (2008). Nimesulide 90 mg Orally Twice Daily Does Not Influence Postoperative Morphine Requirements After Major Chest Surgery. Anesthesia & Analgesia. 106(1). 294–300. 2 indexed citations
18.
Toomey, Sinéad, Brendan Harhen, Helen M. Roche, Desmond J. Fitzgerald, & Orina Belton. (2005). Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis. 187(1). 40–49. 107 indexed citations
19.
Granström, Elisabeth, et al.. (1999). Optimization of an Enzyme Immunoassay for 11-Dehydro-Thromboxane B2 in Urine. Thrombosis Research. 96(6). 427–436. 33 indexed citations
20.
Harhen, Brendan & Frank Barry. (1990). Immobilization of proteolytic enzymes. Biochemical Society Transactions. 18(2). 314–315. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026